Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
Gut Microbiome: A Potential Indicator for Differential Diagnosis of Major Depressive Disorder and General Anxiety Disorder.
复制标题
肠道微生物组:鉴别诊断重度抑郁症和广泛性焦虑症的潜在指标
DOI:
10.3389/fpsyt.2021.651536
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Kuang W
中科院分区:
文献类型:
--
作者:
Dong Z;Shen X;Hao Y;Li J;Li H;Xu H;Yin L;Kuang W
Background: Major depressive disorder (MDD) and general anxiety disorder (GAD) share many common features, leading to numerous challenges in their differential diagnosis. Given the importance of the microbiota–gut–brain axis, we investigated the differences in gut microbiota between representative cases of these two diseases and sought to develop a microbiome-based approach for their differential diagnosis. Methods: We enrolled 23 patients with MDD, 21 with GAD, and 10 healthy subjects (healthy crowd, HC) in the present study. We used 16S rRNA gene-sequencing analysis to determine the microbial compositions of the gut microbiome based on Illumina Miseq and according to the standard protocol. Results: GAD showed a significant difference in microbiota richness and diversity as compared with HC. Additionally, Otu24167, Otu19140, and Otu19751 were significantly decreased in MDD relative to HC, and Otu2581 and Otu10585 were significantly increased in GAD relative to MDD. At the genus level, the abundances of Sutterella and Fusicatenibacter were significantly lower in MDD relative to HC, and the abundances of Fusicatenibacter and Christensenellaceae_R7_group were significantly lower in GAD than in HC. The abundance of Sutterella was significantly higher whereas that of Faecalibacterium was significantly lower in GAD relative to MDD. Moreover, we observed that Christensenellaceae_R7_group negatively correlated with the factor score (Limited to Hopelessness) and total score of HAMD-24 (p < 0.05), whereas Fusicatenibacter negatively correlated with FT4 (p < 0.05). Furthermore, the GAD group showed significant differences at the genus level for Faecalibacterium, which negatively correlated with PTC (p < 0.05). Conclusions: This study elucidated a unique gut-microbiome signature associated with MDD and GAD that could facilitate differential diagnosis and targeted therapy.
登录
查看更多内容
DOI:
10.1007/s13311-017-0600-5
发表时间:
2018-01
期刊:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
影响因子:
--
作者:
Farzi A;Fröhlich EE;Holzer P
通讯作者:
Holzer P
影响因子:
3.2
作者:
Chen JJ;Zheng P;Liu YY;Zhong XG;Wang HY;Guo YJ;Xie P
通讯作者:
Xie P
影响因子:
4.4
作者:
Bartram, Andrea K.;Lynch, Michael D. J.;Neufeld, Josh D.
通讯作者:
Neufeld, Josh D.
DOI:
10.1016/j.bbi.2016.12.010
发表时间:
2017-05
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
Dickerson F;Severance E;Yolken R
通讯作者:
Yolken R
影响因子:
6.6
作者:
Chen Yi-huan;Bai Jie;Peng Zheng-wu
通讯作者:
Peng Zheng-wu